Literature DB >> 11593644

Expression of ICAM-1, B7.1 and TPO on human thyrocytes induced by IFN-alpha.

X You1, W Teng, Z Shan.   

Abstract

OBJECTIVE: To detect expression of intercellular adhesion molecule-1 (ICAM-1), B7.1 and thyroid peroxidase (TPO) on thyrocyte and study the possible mechanism of interferon-alpha (IFN-alpha) in the pathogenesis of autoimmune thyroid disease (AITD).
METHODS: Thyrocytes were cultured from 6 normal persons. Antigen expression on thyrocytes induced by cytokines was examined using immunofluorescence staining with flow cytometer.
RESULTS: IFN-alpha significantly stimulated the expression of ICAM-1, B7.1 and TPO, as compared with those of control group. IFN-gamma markedly enhanced the expression of HLA-DR and ICAM-1, but not B7.1. Prolactin (PRL) resulted in increased expression of ICAM-1, B7.1, as well as overexpression of TPO, which is more significant than that stimulated by IFN-alpha.
CONCLUSIONS: Thyroid autoimmunity induced by IFN-alpha is associated with the expression of ICAM-1, B7.1 and TPO. IFN-gamma could not induce the expression of B7.1, therefore it is not an initiator in AITD. In addition, we should pay more attention to PRL which possibly plays an important role in the initiation and perpetuation of postpartum thyroiditis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11593644

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  8 in total

1.  Regulation of host cell transcriptional physiology by the avian pneumovirus provides key insights into host-pathogen interactions.

Authors:  Shirin Munir; Vivek Kapur
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Side effects of interferon-alpha therapy.

Authors:  Stefan Sleijfer; Marjolein Bannink; Arthur R Van Gool; Wim H J Kruit; Gerrit Stoter
Journal:  Pharm World Sci       Date:  2005-12

Review 3.  Hepatitis C and interferon induced thyroiditis.

Authors:  Yaron Tomer
Journal:  J Autoimmun       Date:  2010-05       Impact factor: 7.094

Review 4.  Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation.

Authors:  Yi-chi M Kong; Wei-Zen Wei; Yaron Tomer
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

5.  MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro.

Authors:  Trevor E Angell; Melissa G Lechner; Julie K Jang; Jonathan S LoPresti; Alan L Epstein
Journal:  Clin Cancer Res       Date:  2014-10-07       Impact factor: 12.531

Review 6.  Environmental triggers of thyroiditis: hepatitis C and interferon-α.

Authors:  F Menconi; A Hasham; Y Tomer
Journal:  J Endocrinol Invest       Date:  2010-02-28       Impact factor: 4.256

Review 7.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

Review 8.  Interferon induced thyroiditis.

Authors:  Yaron Tomer; Francesca Menconi
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-12       Impact factor: 4.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.